Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Tang

Showing results (1401-1410 of 1,415) with videos related to

Pageof 142
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 2, 2023
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjectsXin-Mei Yang, Yang Yang, Bu-Fan Yao, et al.
Medcomm|April 22, 2024
Right ventricular volume and function by three-dimensional echocardiography: results of the echocardiographic measurements in normal Chinese adults (EMINCA) IIYu Zhang, Ying-Bin Wang, Gui-Hua Yao, et al.
The New England Journal of Medicine|January 8, 2025
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis BJinlin Hou, Wenhong Zhang, Qing Xie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2019
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Wei Zhao, Changhyeong Lee, et al.
BMC Infectious Diseases|July 14, 2019
Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in ChinaBing Ruan, Zhixin Yu, Shigui Yang, et al.
Signal Transduction and Targeted Therapy|December 31, 2024
Malate initiates a proton-sensing pathway essential for pH regulation of inflammationYu-Jia-Nan Chen, Rong-Chen Shi, Yuan-Cai Xiang, et al.
BMC Medical Education|March 26, 2021
Career choice and influential factors among medical students majoring in psychiatry in ChinaYing-Jian Zhang, Kai Yuan, Su-Hua Chang, et al.
Space Science Reviews|October 14, 2024
The Mapping Imaging Spectrometer for Europa (MISE)Diana L Blaney, Karl Hibbitts, Serina Diniega, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2018
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trialLai Wei, Seng Gee Lim, Qing Xie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 4, 2026
Peginterferon α-2b Enhances HBsAg Loss in NA-Suppressed Low-HBsAg Chronic Hepatitis B Patients: Everest Study in ChinaChan Xie, Bingliang Lin, Zhishuo Mo, et al.
Pageof 142

Showing results (1401-1410 of 1,415) with videos related to

Sort By:
Pageof 142
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 2, 2023
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjectsXin-Mei Yang, Yang Yang, Bu-Fan Yao, et al.
Medcomm|April 22, 2024
Right ventricular volume and function by three-dimensional echocardiography: results of the echocardiographic measurements in normal Chinese adults (EMINCA) IIYu Zhang, Ying-Bin Wang, Gui-Hua Yao, et al.
The New England Journal of Medicine|January 8, 2025
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis BJinlin Hou, Wenhong Zhang, Qing Xie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2019
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Wei Zhao, Changhyeong Lee, et al.
BMC Infectious Diseases|July 14, 2019
Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in ChinaBing Ruan, Zhixin Yu, Shigui Yang, et al.
Signal Transduction and Targeted Therapy|December 31, 2024
Malate initiates a proton-sensing pathway essential for pH regulation of inflammationYu-Jia-Nan Chen, Rong-Chen Shi, Yuan-Cai Xiang, et al.
BMC Medical Education|March 26, 2021
Career choice and influential factors among medical students majoring in psychiatry in ChinaYing-Jian Zhang, Kai Yuan, Su-Hua Chang, et al.
Space Science Reviews|October 14, 2024
The Mapping Imaging Spectrometer for Europa (MISE)Diana L Blaney, Karl Hibbitts, Serina Diniega, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2018
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trialLai Wei, Seng Gee Lim, Qing Xie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 4, 2026
Peginterferon α-2b Enhances HBsAg Loss in NA-Suppressed Low-HBsAg Chronic Hepatitis B Patients: Everest Study in ChinaChan Xie, Bingliang Lin, Zhishuo Mo, et al.
Pageof 142